Literature DB >> 7698972

The adenosquamous lung carcinoma: clinical and pathological characteristics.

H S Hofmann1, J Knolle, H Neef.   

Abstract

The adenosquamous carcinoma is a rare combined tumour of non-small cell lung cancer (NSCLC). The survival prognosis of surgically treated patients with adenosquamous carcinoma and patients with squamous cell carcinoma, large cell carcinoma or adenocarcinoma were compared during a study. Two hundred and seventyfive patients who had been treated surgically because of primary lung cancer in the Department of Thoracic-Surgery at the Martin-Luther-University Halle-Wittenberg between 1980 and 1989 were evaluated. The five year survival study of 172 patients who underwent resection because of squamous cell carcinoma was 45%, the one of patients with adenocarcinoma (n = 84) was 27%. 26% was the five year survival rate of the patients (n = 9) with large cell carcinoma. Of 13 patients (4%) with adenosquamous carcinoma none survived five years after surgical treatment. The two year survival rate was 28%. The presented results demonstrate the poor survival prognosis of patients suffering from adenosquamous carcinoma and ask for an adjuvant therapy.

Entities:  

Mesh:

Year:  1994        PMID: 7698972

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  7 in total

1.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

Authors:  H Kanazawa; M Ebina; N Ino-Oka; M Shimizukawa; T Takahashi; S Fujimura; T Imai; T Nukiwa
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.

Authors:  Hirotake Komatsu; Shinichi Egawa; Fuyuhiko Motoi; Takanori Morikawa; Naoaki Sakata; Takeshi Naitoh; Yu Katayose; Kazuyuki Ishida; Michiaki Unno
Journal:  Surg Today       Date:  2014-06-29       Impact factor: 2.549

3.  Treatment for Patients With Early Stage Adenosquamous Lung Cancer.

Authors:  Jiaxi He; Shuben Li; Hui Pan; Jianxing He
Journal:  JTO Clin Res Rep       Date:  2020-03-04

4.  Long-term effects of neonatal exposure to hydroxylated polychlorinated biphenyls in the BALB/cCrgl mouse.

Authors:  Jeanelle M Martinez; L Clifton Stephens; Lovell A Jones
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

5.  Clinical characteristics and prognostic significance of 92 cases of patients with primary mixed-histology lung cancer.

Authors:  Pengbo Deng; Chengping Hu; Lihua Zhou; Yuanyuan Li; Li Huang
Journal:  Mol Clin Oncol       Date:  2013-06-14

6.  Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma.

Authors:  Xiangkun Han; Fuming Li; Zhaoyuan Fang; Yijun Gao; Fei Li; Rong Fang; Shun Yao; Yihua Sun; Li Li; Wenjing Zhang; Huimin Ma; Qian Xiao; Gaoxiang Ge; Jing Fang; Hongda Wang; Lei Zhang; Kwok-kin Wong; Haiquan Chen; Yingyong Hou; Hongbin Ji
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 7.  Evolution from genetics to phenotype: reinterpretation of NSCLC plasticity, heterogeneity, and drug resistance.

Authors:  Yingjiao Xue; Shenda Hou; Hongbin Ji; Xiangkun Han
Journal:  Protein Cell       Date:  2016-10-18       Impact factor: 14.870

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.